# Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis

> **NCT05142774** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 728 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Tapinarof cream, 1%

## Key facts

- **NCT ID:** NCT05142774
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-28
- **Primary completion:** 2024-02-29
- **Final completion:** 2024-03-07
- **Target enrollment:** 728 (ACTUAL)
- **Last updated:** 2025-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05142774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05142774, "Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT05142774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*